COVID-19: Ethiopia to Get 300,000 Doses Of Sinopharm Vaccine

ADDIS ABABA – Ethiopia will receive 300,000 COVID-19 vaccine doses from China’s state-backed China National Pharmaceutical Group (Sinopharm) on Tuesday, reported Reuters news agency.

The Sinopharm doses are the first shots Ethiopia has secured outside the global COVAX vaccine-sharing initiative, Health Minister Lia Tadesse was quoted as saying by the news agency on Monday.



Ethiopia started to administer the COVID-19 vaccine on March 13, 2021, a week after its health officials received 2.2 million doses of the AstraZeneza vaccine through COVAX.

The Ministry of Health plans to inoculate at least a fifth of the country’s 110 million people by the end of the year.

Share this